Skip to content

Clinical trials

Phase 1 Recurrence trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1 Country / region: China Clear all

179 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20152
20163
20179
201810
201921
20206
202115
202215
202317
202421
202532
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status61
Recruiting59
Not yet recruiting20
Completed13
Terminated10
Active, not recruiting8
Withdrawn7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China9
The First Affiliated Hospital with Nanjing Medical University7
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology7
Second Affiliated Hospital, Zhejiang University, School of Medicine5
The First Affiliated Hospital of Soochow University5
Hrain Biotechnology Co., Ltd.4
Zhejiang University4
Affiliated Hospital to Academy of Military Medical Sciences3
Chinese PLA General Hospital3
Henan Cancer Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence179
Multiple Myeloma31
Lymphoma, B-Cell22
Leukemia, Myeloid, Acute18
Lymphoma14
Lymphoma, Non-Hodgkin12
Hematologic Neoplasms11
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Lupus Erythematosus, Systemic7
Autoimmune Diseases6

Trials

Showing 1 to 25 of 179. Each trial links to its page on Pharma Observatory.

79 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.